Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-02-15 Sale | 2023-02-17 4:21 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer | 3,173 | $0.5418 | $1,719 | 227,018 (Direct) | View |
| 2020-08-03 Purchase | 2020-08-05 7:36 pm | OncoCyte Corp | OCX | Parker Albert P Chief Operating Officer | 5,000 | $1.3296 | $6,648 | 5,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-10-10 Disposition | 2023-10-11 10:02 am | N/A 2032-02-14 | Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer | 200,000 | $0 | 0 (Direct) | View |
| 2023-10-10 Equity Swap | 2023-10-11 10:02 am | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer | 312,018 | $0 | 0 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-11 10:02 am | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer | 85,000 | $0 | 0 (Direct) | View |
| 2023-02-08 Tax Withholding | 2023-02-09 5:09 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer | 5,463 | $0.5965 | 230,191 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 5:09 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer | 18,864 | $0 | 230,191 (Direct) | View |
| 2023-02-01 Tax Withholding | 2023-02-02 8:12 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer | 5,841 | $0.5952 | 216,790 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 8:12 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer | 17,631 | $0 | 216,790 (Direct) | View |
| 2023-01-24 Option Award | 2023-01-25 5:30 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer | 170,000 | $0 | 205,000 (Direct) | View |
| 2022-02-14 Option Award | 2022-02-15 4:13 pm | N/A 2032-02-14 | Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer | 235,000 | $0 | 235,000 (Direct) | View |
| 2020-12-11 Option Award | 2020-12-15 06:20 am | N/A N/A | OncoCyte Corp | OCX | Parker Albert P COO | 5,586 | $0 | 10,586 (Direct) | View |
| 2020-02-10 Option Award | 2020-02-12 9:53 pm | N/A 2030-02-09 | Oncocyte Corp | OCX | Parker Albert P Chief Operating Officer | 204,000 | $0 | 204,000 (Direct) | View |